These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1370433

  • 1. Genetic control of immune responses in mice to synthetic peptides of a Streptococcus mutans surface protein antigen.
    Takahashi I, Matsushita K, Nisizawa T, Okahashi N, Russell MW, Suzuki Y, Munekata E, Koga T.
    Infect Immun; 1992 Feb; 60(2):623-9. PubMed ID: 1370433
    [Abstract] [Full Text] [Related]

  • 2. Identification of antigenic epitopes in a surface protein antigen of Streptococcus mutans in humans.
    Matsushita K, Nisizawa T, Nagaoka S, Kawagoe M, Koga T.
    Infect Immun; 1994 Sep; 62(9):4034-42. PubMed ID: 7520424
    [Abstract] [Full Text] [Related]

  • 3. Identification of antigenic epitopes in an alanine-rich repeating region of a surface protein antigen of Streptococcus mutants.
    Okahashi N, Takahashi I, Nakai M, Senpuku H, Nisizawa T, Koga T.
    Infect Immun; 1993 Apr; 61(4):1301-6. PubMed ID: 7681043
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of peptides coupled with multiple T-cell epitopes of a surface protein antigen of Streptococcus mutans.
    Senpuku H, Iizima T, Yamaguchi Y, Nagata S, Ueno Y, Saito M, Hanada N, Nisizawa T.
    Immunology; 1996 Jun; 88(2):275-83. PubMed ID: 8690461
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [Abstract] [Full Text] [Related]

  • 7. An antigenic peptide inducing cross-reacting antibodies inhibiting the interaction of Streptococcus mutans PAc with human salivary components.
    Senpuku H, Miyauchi T, Hanada N, Nisizawa T.
    Infect Immun; 1995 Dec; 63(12):4695-703. PubMed ID: 7591125
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of human antigenic epitopes in an alanine-rich repeating region using sera from hu-PBL-SCID mice immunized with a surface protein antigen of Streptococcus mutans.
    Senpuku H, Iizima T, Koga T, Nisizawa T.
    Oral Microbiol Immunol; 1996 Oct; 11(5):343-9. PubMed ID: 9028261
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Epitope mapping of Streptococcus mutans SR protein and human IgG cross-reactive determinants, by using recombinant proteins and synthetic peptides.
    Gangloff S, M'Zoughi R, Lett E, Scholler M, Baer J, Pini A, Ogier J, Klein JP.
    J Immunol; 1992 May 15; 148(10):3249-55. PubMed ID: 1374451
    [Abstract] [Full Text] [Related]

  • 12. The effect of amino acid spacers on the antigenicity of dimeric peptide--inducing cross-reacting antibodies to a cell surface protein antigen of Streptococcus mutans.
    Oishi Y, Onozuka A, Kato H, Shimura N, Imai S, Nisizawa T.
    Oral Microbiol Immunol; 2001 Feb 15; 16(1):40-4. PubMed ID: 11169138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structural aspects of a protein epitope and their role in the major histocompatibility complex control of T cell responsiveness.
    Mackewicz CE, Langton BC, Leung CY, Benjamini E.
    Cell Immunol; 1991 Mar 15; 133(1):55-71. PubMed ID: 1703927
    [Abstract] [Full Text] [Related]

  • 20. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H, Saito K, Kubota E.
    J Immunol; 1989 Mar 01; 142(5):1495-9. PubMed ID: 2918225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.